Search results
Results from the WOW.Com Content Network
Screening is recommended for women between ages 21 and 65, regardless of age at sexual initiation or other high-risk behaviors. [17] [18] [19] For healthy women aged 21–29 who have never had an abnormal Pap smear, cervical cancer screening with cervical cytology (Pap smear) should occur every 3 years, regardless of HPV vaccination status. [11]
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
Currently, the pap smear — in which cells taken from the cervix are examined by a doctor “for cervical cancer or cell changes,” per the National Cancer Institute — is the recommended ...
Cervical cancer screening, such as the Papanicolaou test ("pap smear"), or examination of the cervix after applying acetic acid, can detect both early cancer and abnormal cells that may develop into cancer. [1] Screening allows for early treatment which results in better outcomes. [1]
According to Dr. Harrison, “Women should stop having cervical cancer screening after age 65 if they do not have a history of abnormal cervical cells or cervical cancer, and they have had either ...
The two screening methods available are the Pap smear and testing for HPV. CIN is usually discovered by a screening test, the Pap smear. The purpose of this test is to detect potentially precancerous changes through random sampling of the transformation zone. Pap smear results may be reported using the Bethesda system (see above).
The guideline did not consider the necessity or frequency of Pap smears. The ACP guideline concluded that there was no evidence that the exam in asymptomatic adult women reduced morbidity or mortality, and that there were no studies that addressed the exam's diagnostic accuracy for identifying specific gynecologic conditions. [7]
Cervicography is no more sensitive than Pap smear screening, and has a higher false positive rate (thus increasing the number of colposcopies needed). [3] [4] Whether cervicography could have a role in countries where Pap smear screening programs are not in place depends on cost effectiveness and remained to be determined as of 1998. [4]